Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation |
|---|
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
Exertional desaturation is a feature of COVID-19. The study will measure vital signs of patients discharge by practitioners in primary care, secondary care or by paramedic practitioners. Patients will then undertake a 40-steps on the spot walk followed by measurements of heart rate and oxygen saturations for up to two minutes. Association of desaturation with 30 days hospital admission and mortality will be reported.
Description: No change Further investigations Hospital admission a) No change b) Further investigations c) Hospital admission
Measure: Change in decision to discharge Time: 24 hoursDescription: Admission to hospital within 30 days of the test
Measure: Hospital Time: 30 daysDescription: Death within 30 days of the test
Measure: Death Time: 30 daysDescription: Proportion of sites and patients able to undertake the test
Measure: Feasibility of the 40-steps test Time: 12 monthsDescription: Change in heart rate compared to value measured before expercise
Measure: Change in heart rate Time: Within 2 minutes of completion of the testDescription: Change in heart rate compared to value measured before exercise
Measure: Change in oxygen saturations Time: Within 2 minutes of completion of the testDescription: Change in respiratory rate compared to value measured before exercise
Measure: Change in respiratory rate Time: Within 2 minutes of completion of the testDescription: Change in breathlessness compared to value measured before exercise
Measure: Change in breathlessness Time: Within 2 minutes of completion of the testAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports